Human RPN2 Derived Peptides Useful for Treating Cancer
Patent Cooperation Treaty
PCT/US2016/053352
Filed on 2016-09-23
PCT/US2016/053352
Filed on 2016-09-23
LINKED PURINE PTERIN HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS
US Application 15/255,466
Filed on 2016-09-02
Filed on 2016-09-02
PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS
Australia
2016238894
Filed on 2016-10-06
2016238894
Filed on 2016-10-06
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Singapore
11201604868Y
Filed on 2014-12-16
11201604868Y
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Mexico
MX/a/2016/007726
Filed on 2014-12-16
MX/a/2016/007726
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
South Korea
10-2016-7019097
Filed on 2016-07-14
10-2016-7019097
Filed on 2016-07-14
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP REPLICON
India
201617023312
Filed on 2014-12-16
201617023312
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Hong Kong
17105504.9
Filed on 2017-06-02
17105504.9
Filed on 2017-06-02
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
China
201480074163.2
Filed on 2014-12-16
201480074163.2
Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Brazil
BR112016013804-0
Filed on 2014-12-16
BR112016013804-0
Filed on 2014-12-16